The expression levels of early HCC markers BIRC5, HSP70, LYVE and EZH2, angiogenesis marker VEGFA and immune checkpoint CD274 significantly correlated with both central tendency and heterogeneity parameters. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.